RICHARD BURGAN: Open Payments
NPI 1043324569 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,101 in 67 payments from 15 companies in 2025. Trend: 2023 $1,063 · 2024 $975 · 2025 $1,101
Food & beverage: $1,101
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 17 | $252 |
| PFIZER INC. | 13 | $169 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 9 | $155 |
| Merck Sharp & Dohme LLC | 8 | $147 |
| Boston Scientific Corporation | 3 | $64 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $63 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $45 |
| Alnylam Pharmaceuticals Inc. | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| ABIOMED | 1 | $33 |
Products named: ELIQUIS, LifeVest, VERQUVO, CAMZYOS, JARDIANCE, VYNDAQEL, Kerendia, FARXIGA.
Industry payments across KY — which companies pay providers there.
